Docsed indications
Docsed syrup is indicated for the treatment of cough.
Docsed side effects
Codeine (Docsed) phosphate in normal doses may cause nausea, vomiting, constipation, drowsiness and confusion.
Side-effects with antihistamines vary in incidence and severity with each patient. The following side-effects have been reported for drugs in the antihistamine class: dizziness, lassitude, hypotension, muscular weakness and inco-ordination, nausea, vomiting, diarrhoea or constipation, colic and epigastric pain. Antihistamines may also produce headache, hallucinations, blurred vision, tinnitus, elation or depression, irritability, anorexia, difficulty in micturition, dryness of the mouth, tightness of the chest and weakness of the hands. Large doses of antihistamines may precipitate fits in epileptics. Blood dyscrasias, including agranulocytosis, haemolytic anaemia and thrombocytopenic purpura, though rare, have been reported.
Ephedrine (Docsed) hydrochloride may produce an undesirably high blood pressure with headache, vomiting and, rarely, palpitations. Reflex bradycardia may occur which can be prevented or abolished with atropine.
As with all drugs, care should be taken when administering this preparation during the first trimester of pregnancy.
Chloroform depresses respiration and may produce hypotension.
Docsed contraindications
Hypersensitivity to mepyramine maleate or Codeine (Docsed) phosphate. Codeine (Docsed) phosphate is contra-indicated in respiratory depression, the presence of acute alcoholism or in patients with obstructive bowel disorders.
Ephedrine (Docsed) hydrochloride, a sympathomimetic agent, should be avoided or only used with great caution in hypersusceptible patients or those with hyperthyroidism, aneurysm, hypertension, arteriosclerosis, and cardiovascular disorders such as ventricular tachycardia, myocardial disease or bradycardia.
It should not be given to patients being treated with a monoamine oxidase inhibitor or within 14 days of stopping such treatment. It should also be avoided in patients receiving tricyclic antidepressants. Patients receiving guanethidine and similar adrenergic neurone blocking agents are extremely sensitive to the hypertensive effects of Ephedrine (Docsed); Ephedrine (Docsed) may also markedly reverse the hypotensive effects of reserpine and methyldopa. In patients with prostatic enlargement, Ephedrine (Docsed) may increase difficulty with micturition.
Chloroform should not be administered to patients with renal, hepatic or cardiovascular disease, diabetes, mellitus or severe anaemia.
Active ingredient matches for Docsed:
Codeine/Ephedrine/Pholcodine/Pyrilamine
Codeine Phosphate/Ephedrine Hcl/Mepyramine Maleate/Pholcodine
List of Docsed substitutes (brand and generic names) | Sort by popularity |
| Unit description / dosage (Manufacturer) | Price, USD |
| Codeine Phosphate/Ephedrine Hcl/Mepyramine Maleate/Pholcodine | |
| Codeine/Ephedrine/Pholcodine/Pyrilamine | |
References
- DailyMed. "EPHEDRINE SULFATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- DailyMed. "CODEINE SULFATE: DailyMed provides trustworthy information about marketed drugs in the United States. DailyMed is the official provider of FDA label information (package inserts).". https://dailymed.nlm.nih.gov/dailyme... (accessed September 17, 2018).
- PubChem. "Ephedrine". https://pubchem.ncbi.nlm.nih.gov/com... (accessed September 17, 2018).
Reviews
The results of a survey conducted on ndrugs.com for Docsed are given in detail below. The results of the survey conducted are based on the impressions and views of the website users and consumers taking Docsed. We implore you to kindly base your medical condition or therapeutic choices on the result or test conducted by a physician or licensed medical practitioners.User reports
Consumer reported useful
No survey data has been collected yetConsumer reported price estimates
No survey data has been collected yetConsumer reported time for results
No survey data has been collected yet6 consumers reported age
| Users | % | ||
|---|---|---|---|
| 30-45 | 2 | 33.3% | |
| 6-15 | 2 | 33.3% | |
| > 60 | 1 | 16.7% | |
| < 1 | 1 | 16.7% | |
Consumer reviews
There are no reviews yet. Be the first to write one! |
Information checked by Dr. Sachin Kumar, MD Pharmacology
